GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (BOM:524558) » Definitions » Days Sales Outstanding

Neuland Laboratories (BOM:524558) Days Sales Outstanding : 88.53 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Neuland Laboratories Days Sales Outstanding?

Neuland Laboratories's average Accounts Receivable for the three months ended in Mar. 2024 was ₹3,735 Mil. Neuland Laboratories's Revenue for the three months ended in Mar. 2024 was ₹3,850 Mil. Hence, Neuland Laboratories's Days Sales Outstanding for the three months ended in Mar. 2024 was 88.53.

The historical rank and industry rank for Neuland Laboratories's Days Sales Outstanding or its related term are showing as below:

BOM:524558' s Days Sales Outstanding Range Over the Past 10 Years
Min: 80.8   Med: 91.57   Max: 133.48
Current: 82.76

During the past 13 years, Neuland Laboratories's highest Days Sales Outstanding was 133.48. The lowest was 80.80. And the median was 91.57.

BOM:524558's Days Sales Outstanding is ranked worse than
61.62% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs BOM:524558: 82.76

Neuland Laboratories's Days Sales Outstanding increased from Mar. 2023 (81.09) to Mar. 2024 (88.53).


Neuland Laboratories Days Sales Outstanding Historical Data

The historical data trend for Neuland Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuland Laboratories Days Sales Outstanding Chart

Neuland Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.02 80.80 89.16 91.33 86.10

Neuland Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.09 90.94 70.97 75.47 88.53

Competitive Comparison of Neuland Laboratories's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuland Laboratories's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Neuland Laboratories's Days Sales Outstanding falls into.



Neuland Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Neuland Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

Days Sales Outstanding (A: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (3617.68 + 3735.262) / 2 ) / 15585.805*365
=3676.471 / 15585.805*365
=86.10

Neuland Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0 + 3735.262) / 1 ) / 3850.097*365 / 4
=3735.262 / 3850.097*365 / 4
=88.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuland Laboratories  (BOM:524558) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Neuland Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Neuland Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuland Laboratories (BOM:524558) Business Description

Traded in Other Exchanges
Address
Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033
Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (BOM:524558) Headlines

No Headlines